Sinopharm Tech Holdings Limited (stock code: 08156) released its monthly return for the period ended 31 October 2025. The authorized share capital remained at HKD 200,000,000, comprising 12.8 billion ordinary shares and 3.2 billion preference shares at par value HKD 0.0125 each. No changes in the authorized capital were recorded during the month.

The number of issued ordinary shares stood at 633,693,055, while the number of issued convertible preference shares was 1,480,151,050, both unchanged from the preceding month. A share option scheme remains in effect, with 5,440,000 outstanding share options carrying an adjusted exercise price of HKD 1. There were no new shares issued in connection with the scheme during this period.

The convertible preference shares, amounting to HKD 148,015,105, are convertible at HKD 0.1 per share, with a maximum potential of 1,480,151,050 underlying ordinary shares. No new issue or conversion of these preference shares was recorded during the month.